Wikisage, the free encyclopedia of the second generation, is digital heritage

Epilepsy: Difference between revisions

From Wikisage
Jump to navigation Jump to search
([[)
(riluzole)
Line 51: Line 51:


|}
|}
[[File:Riluzole.svg.png|thumb|riluzole]]
[[File:2000px-Sultiame.svg.png|thumb|sulthiame]]
[[File:2000px-Sultiame.svg.png|thumb|sulthiame]]
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480532/pdf/10.1177_1756285615589711.pdf A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures]
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480532/pdf/10.1177_1756285615589711.pdf A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures]

Revision as of 20:54, 30 October 2018

Classification of ethiology could divided in four categories:

[1] It is difficult to distinguish between genetic and cryptogenic syndromes.

Morbility data is difficult to interpret when WHO[2] states 50-70 millions persons[3] suffers epilepsy[4]

nonadherence appears to be associated with increased health care costs, nevertheless XR-medicine appears as strategy to overcome compliance with AED[5]

eslicarbazepine

Medicines

type  ,,, ,,,,
INN  Generic slow release
carbamazepine  normal xr
lamotrigine  normal Lamictal XR[6]
levetiracetam  normal xr
oxcarbazepine  oxcarbazepine xr
phenytoin  ... xr
valproate  xr
topiramate  xr

AED

riluzole
sulthiame

A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures

Eslicarbazepine acetate for the treatment of focal epilepsy:an update on its proposed mechanisms of action

In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein

Diverse Mechanisms of Antiepileptic Drugs in the Development Pipeline


ILAE Classification

[7] [8] [9] [10] ILAE Overview

See also

A new perspective for Epileptic Disorders

Links

Q41571 at Wikidata  Interwiki via Wikidata

Epilepsies: diagnosis and management clinical guide

Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population

The Efficacy of Leviteracetam versus Carbamazepine for Epilepsy: A Meta-Analysis

The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs

Models of epilepsy


purinergic signalling:therapeutic developments


Electroencephalography in the Diagnosis of Genetic Generalized Epilepsy Syndromes

Ranking the Leading Risk Factors for Sudden Unexpected Death in Epilepsy

Lennox-Gastaut Syndrome

BECTS

Dravet's syndrome

Status epilepticus

Panayiotopoulos syndrome
epilepsia partialis continua

West's syndrome

Ohtahara syndrome

Pretzel syndrome

Doose syndrome

References

References:
  1. ↑ The etiologic classification of epilepsy
  2. ↑ http://www.who.int/en/
  3. ↑ (Li et al 2014)
  4. ↑ (Chung 2015)
  5. ↑ (Davis et al 2008)
  6. ↑ http://www.rxlist.com/lamictal-xr-drug.htm
  7. ↑ http://www.who.int/mediacentre/factsheets/fs999/en/
  8. ↑ epilepsy is not resolved. Epilepsy Currents 14 2014
  9. ↑ https://www.ligaepilepsia.cl/epilepsias/tipos-de-epilepsia
  10. ↑ Annie T Berg et al.2010 Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009 Epilepsia 51 676-685
Retrieved from "https://en.wikisage.org/w/index.php?title=Epilepsy&oldid=7314"